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Abstract
Background: Periodontitis is associated with elevated levels of C-reactive protein and fibrinogen
and it may be a coronary heart disease risk factor. We wanted to study if treatment of periodontitis
can decrease the levels of these inflammatory markers.
Methods: C-reactive protein and fibrinogen levels were measured in 35 patients (21 M, 14 F, mean
age 50 years) with adult periodontitis, before and after treatment.
Results:  The median baseline C-reactive protein level in the patients was 1.05 mg/l and it
decreased to 0.7 mg/l (p = 0.05) after periodontal treatment. Of the 30 patients who could be
included in the analyses, 24 patients had a baseline level below 2 mg/l (the 95th percentile limit in
Finland); 6 patients had levels higher than this. Elevation of the baseline C-reactive protein level or
the magnitude of its decrease were not associated with severe form of periodontitis. The decrease
in C-reactive protein levels was at least 50 % in 4/6 of those with elevated baseline levels, as
compared with 3/24 of the rest of the patients (p = 0.016). No corresponding effect was observed
in fibrinogen levels.
Conclusions:  Periodontitis seems to increase C-reactive protein only in some individuals,
presumably the ones reacting to it with a systemic inflammatory reaction. Periodontal treatment
decreases C-reactive protein levels in these individuals and it may thus decrease their risk of
coronary heart disease.
Background
Increasing body of evidence shows that C – Reactive Pro-
tein (CRP), measured with a sensitive assay, is an inde-
pendent predictor of coronary heart disease (CHD)
events. Some studies suggest that these elevated CRP lev-
els reflect certain low-grade infections associated with
CHD, like periodontitis and infections caused by cytome-
galovirus and Chlamydia pneumoniae [1]. Some recent
studies have shown that the combination of chronic infec-
tion and elevated CRP level is associated with a signifi-
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cantly higher CHD risk than either of these factors alone
[2,3]. These observations raise the possibility that chronic
infections may be CHD risk factors mostly or only in these
"susceptible" individuals who react to these infections
with a harmful systemic inflammatory reaction, reflected
in elevated levels of CRP. Treating Helicobacter pylori and
Chlamydia pneumoniae infections decreased CRP levels in
the study of Torgano et al [4] but no effect was observed
in the study of Schweeger et al [5].
The average CRP and fibrinogen levels are higher in peri-
odontitis patients than in their controls [6,7]. In the study
of Ebersole et al. [6] CRP levels were significantly higher
(9 vs. 2 mg/l, respectively) in 40 patients with moderate to
severe adult periodontitis than in the 35 control subjects.
Mechanical treatment of periodontitis did not, however,
decrease CRP levels (while it did decrease haptoglobin
levels).
Methods
We measured serum CRP levels before and after periodon-
tal treatment in 35 patients with adult periodontitis. The
inclusion criteria were: inflamed periodontitis indicating
clinical and/or radiographic loss of periodontal attach-
ment, the number of teeth in the dentition at least 15, no
positive history or symptoms of CHD or other significant
systemic disease (e.g. diabetes or inflammatory condi-
tions like rheumatoid arthritis), and no acute infections
(e.g. common cold, sinusitis etc.) within 2 months before
the entry to the study.
Periodontitis was classified as severe when alveolar bone
loss was found around more than 25% of the teeth, in-
cluding at least 2 teeth with bone loss over the cervical
third of the root length from which more than one was a
molar tooth with bone loss to the apical half of the root.
Periodontal treatment comprised traditional mechanical
therapy and, when indicated, metronidazole 500 mg bid
for 7 days.
CRP and fibrinogen levels were measured at baseline and
6 weeks after the completion of periodontal treatment.
CRP levels were determined with a sensitive sandwich en-
zyme immunoassay (UC CRP ELISA, Eucardio Laborato-
ry). With this method, 2 mg/l is the 95th percentile limit
in Finnish population, and CRP measured with this assay
has been shown to predict coronary events, especially
when co-occurring with certain infections [3]. Plasma fi-
brinogen levels were determined with Clauss method,
with 3.6 g/l being the 95th percentile limit.
Laboratory values observed before and after the treatment
were compared with paired t-test (after logarithmic con-
version when necessary); Fisher' exact test or Mann-Whit-
ney' test was used to compare the patient groups of those
with baseline CRP levels above and below 2 mg/l and
those with moderate and severe periodontitis, respective-
ly.
The study protocol was approved by the ethics committee
and informed consent was obtained from all participants
before entering the study.
Results
Twenty-one of the patients were males and 14 females; the
mean age was 50 years, with a range of 32 to 69 years. 16
subjects belonged to social class I, 9 to social class II, 10 to
social class III. Seven of the patients were current smokers,
4 were ex-smokers, the rest had never smoked. None of
the subjects changed their smoking habits during the
study. The majority of the patients, 28, had severe perio-
dontitis. Nine individuals were given metronidazole. One
of the subjects was excluded from the analyses due to a
respiratory infection occurring immediately after the first
visit. Of the rest, either the pre- or post-therapy blood
sample was missing for 4 patients; thus the remaining 30
patients could be used in the analyses.
CRP and fibrinogen levels are given in Table 1. CRP levels
decreased, on the average, by 0. 34 mg/l (p = 0.05) in the
whole study group. Individuals with severe periodontitis
did not have higher baseline CRP levels or show a greater
decrease in CRP levels. Twenty-four subjects had a base-
line CRP level below 2 mg/l; 6 individuals had levels
greater or equal to this value (data not shown). The de-
crease in CRP levels was at least 50 % in 4/6 of those with
baseline CRP > 2 mg/l and in 3/24 of those with the base-
line CRP below 2 mg/l (p = 0.02), respectively. Only one
patient treated with metronidazole showed a 50 % de-
crease in CRP level. No significant decrease was observed
in fibrinogen levels.
Table 1: CRP and fibrinogen levels in the study population.
Baseline
(median, range)
Post-treatment 
decrease (mean)
Whole study group
CRP (mg/l) 1. 05 (0. 2 – 5. 4) 0. 34*
Fibrinogen (g/l) 3.5 (2.3 – 4.4) 0. 19
Severe periodontitis (n = 24)
CRP (mg/l) 1. 05 (0.2 – 5.4) 0. 30
Fibrinogen (g/l) 3.4 (2.7 – 4.4) 0.05
Moderate periodontitis (n = 6)
CRP (mg/l) 1. 05 (0. 5 – 3. 2) 0. 52
Fibrinogen (g/l) 3. 7 (3. 2 – 4. 2) 0. 77
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Discussion
To our knowledge this is the first study showing that treat-
ing adult periodontitis decreases CRP levels, as measured
with a sensitive assay. The decrease in CRP levels observed
in our study was of the same magnitude as the differences
in CRP levels that have been shown to be associated with
increased CHD risk in several studies [1–3] and somewhat
greater than was observed after treatment of Helicobacter
pylori by Torgano et al [4]. In the study by Ebersole et al
[6], the patients had clearly elevated CRP levels at base-
line, while the CRP levels of our patients were in the so
called "normal range". The method that was used for CRP
measurements in the study of Ebersole et al. may have
been less sensitive in detecting changes induced by perio-
dontal treatment.
The decrease in CRP levels occurred mostly in individuals
with elevated CRP levels at baseline. Elevated baseline
CRP levels or the magnitude of the decrease in the levels
were not associated with the severity of periodontitis or
metronidazole treatment. In contrast to CRP, fibrinogen
levels did not decrease significantly. In most studies, CRP
and fibrinogen have shown similar associations with
CHD and various infections. Our result may be due to
chance. On the other hand, the association of CRP with
various indicators of poor periodontal status may be more
consistent than that of fibrinogen [7] and it might there-
fore be more sensitive to the treatment effect.
Conclusions
As the number of patients in this study was relatively
small, these results have to be interpreted with caution.
Nevertheless, these results are compatible with the view
that only "susceptible" individuals react to periodontitis
with an increase in CRP and that these individuals are not
necessarily the ones with the most severe disease. Treating
periodontitis lowers CRP levels in these individuals, pos-
sibly also reducing their CHD risk.
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